Proposed Chaoyang vascular classification for superior mesenteric-portal vein invasion, resection, and reconstruction in patients with pancreatic head cancer during pancreaticoduodenectomy - A retrospective cohort study

被引:20
|
作者
Zhu, Jiqiao [1 ]
Li, Xianliang [1 ]
Kou, Jiantao [1 ]
Ma, Jun [1 ]
Li, Lixin [1 ]
Fan, Hua [1 ]
Lang, Ren [1 ]
He, Qiang [1 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary & Pancreaticosplen Surg, Beijing Organ Transplant Ctr, 8 Gongtinan Rd, Beijing 100020, Peoples R China
关键词
Pancreaticoduodenectomy; Pancreatic head cancer; Venous resection; Venous reconstruction; INTERNATIONAL STUDY-GROUP; PRESERVING DISTAL PANCREATECTOMY; SURGERY ISGPS; CONSENSUS STATEMENT; ADENOCARCINOMA; DEFINITION; CONSERVATION; CARCINOMA; SURVIVAL; VESSELS;
D O I
10.1016/j.ijsu.2018.04.011
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients with pancreatic head cancer involving the superior mesenteric-portal vein can benefit from vascular resection and reconstruction. We aimed to propose our vascular classification and assess its effect in this study. Material and methods: Data of consecutive patients, who were diagnosed with pancreatic head cancer, and underwent radical pancreaticoduodenectomy combined with superior mesenteric-portal vein resection and reconstruction at our institute between October 2013 and August 2016, were retrospectively collected. On a scale of one to four, our classification was proposed. Perioperative parameters were then analyzed among the four types. Results: There were a total of 52 patients with 11 in type I, 15 in type II, 18 in type III, 8 in type IV. The respective operative time and estimated blood loss of types III (425-990 min, 265-1820 mL) and IV (480-1036 min, 330-1690 mL) were greater than those of types I (300-824 min, 200-1255 mL) and II (369-875 min, 305-1400 mL) (p < 0.05). Type IV had larger tumors (4-7 cm) than type I (1.5-4 cm) (p < 0.05). Percentage of tunica intima involvement and the median survival time of type I (9.1%, 22 months) were lower and longer than those of types II (46.7%, 17 months) and III (44.4%, 16 months; p < 0.05), and even lower and longer than those of type IV (87.5%, 10 months; p < 0.01), respectively. Conclusions: Our classification can provide a system to grade patients with venous invasion in order of surgical difficulty and survival.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 45 条
  • [21] Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes
    Hirono, Seiko
    Kawai, Manabu
    Tani, Masaji
    Okada, Ken-ichi
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    Yamaue, Hiroki
    LANGENBECKS ARCHIVES OF SURGERY, 2014, 399 (04) : 461 - 471
  • [22] Reconstruction of portal vein and superior mesenteric vein after extensive resection for pancreatic cancer
    Kim, Suh Min
    Min, Seung-Kee
    Park, Daedo
    Min, Sang-Il
    Jang, Jin-Young
    Kim, Sun-Whe
    Ha, Jongwon
    Kim, Sang Joon
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2013, 84 (06): : 346 - 352
  • [23] Impact of a portal/superior mesenteric vein resection during pancreatico-duodenectomy for pancreatic head adenocarcinoma
    Dumitrascu, T.
    Dima, S.
    Brasoveanu, V.
    Stroescu, C.
    Herlea, V.
    Moldovan, S.
    Ionescu, M.
    Popescu, I.
    MINERVA CHIRURGICA, 2014, 69 (06) : 301 - 313
  • [24] Direct splenic vein reconstruction combined with resection of the portal vein/superior mesenteric vein confluence during pancreaticoduodenectomy
    Matsuki, Ryota
    Momose, Hirokazu
    Kogure, Masaharu
    Suzuki, Yutaka
    Mori, Toshiyuki
    Sakamoto, Yoshihiro
    LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (05) : 1691 - 1695
  • [25] Direct splenic vein reconstruction combined with resection of the portal vein/superior mesenteric vein confluence during pancreaticoduodenectomy
    Ryota Matsuki
    Hirokazu Momose
    Masaharu Kogure
    Yutaka Suzuki
    Toshiyuki Mori
    Yoshihiro Sakamoto
    Langenbeck's Archives of Surgery, 2021, 406 : 1691 - 1695
  • [26] Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer A Multicenter Study
    Nagakawa, Yuichi
    Jang, Jin-Young
    Kawai, Manabu
    Kim, Song Cheol
    Inoue, Yosuke
    Matsuyama, Ryusei
    Heo, Jin Seok
    Honda, Masayuki
    Sugiura, Teiichi
    Ohtsuka, Masayuki
    Mizuno, Shugo
    Kwon, Wooil
    Uemura, Kenichiro
    Han, Ho-Seong
    Sugimoto, Motokazu
    Okano, Keiichi
    Nakamura, Masafumi
    Wada, Keita
    Kumamoto, Yusuke
    Osakae, Hiroaki
    Tsuchida, Akihiko
    Yoon, Yoo-Seok
    Park, Joon Seong
    Yamaue, Hiroki
    Endo, Itaru
    ANNALS OF SURGERY, 2023, 277 (05) : E1081 - E1088
  • [27] Portal/Superior Mesenteric Vein Reconstruction during Pancreatic Resection Using a Cryopreserved Arterial Homograft
    Mascoli, Chiara
    D'Ambra, Marielda
    Casadei, Riccardo
    Ricci, Claudio
    Taffurelli, Giovanni
    Ancetti, Stefano
    Stella, Andrea
    Minni, Francesco
    Freyrie, Antonio
    DIGESTIVE SURGERY, 2015, 32 (04) : 284 - 290
  • [28] Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study
    Selvaggi, Federico
    Mascetta, Giuseppe
    Daskalaki, Despoina
    dal Molin, Marco
    Salvia, Roberto
    Butturini, Giovanni
    Cellini, Carlo
    Bassi, Claudio
    LANGENBECKS ARCHIVES OF SURGERY, 2014, 399 (05) : 659 - 665
  • [29] 3D-laparoscopic pancreaticoduodenectomy with superior mesenteric or portal vein resection for pancreatic cancer
    Joachim Geers
    Halit Topal
    Joris Jaekers
    Baki Topal
    Surgical Endoscopy, 2020, 34 : 5616 - 5624
  • [30] Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hashimoto, Yasushi
    Nakashima, Akira
    Kondo, Naru
    Nakagawa, Naoya
    Sueda, Taijiro
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (04) : 414 - 421